Global Plasmapheresis Device Market Strategic Research Report

Scope of the Report

The global Plasmapheresis Device market size is predicted to grow from US$ 478 million in 2025 to US$ 637 million in 2032; it is expected to grow at a CAGR of 4.0% from 2026 to 2032.

In 2025, global Plasmapheresis Device production reached approximately 18,060 units, with an average global market price of around US$ 27,057 per unit.

A Plasmapheresis Device is a medical device used in plasmapheresis, a procedure that involves the removal, treatment, and return of plasma from a patient's blood. Plasma is the pale-yellow liquid component of blood that contains water, electrolytes, proteins, and waste products. During plasmapheresis, blood is drawn from the patient’s body, the plasma is separated, and the remaining blood components, such as red blood cells, white blood cells, and platelets, are returned to the body. The removed plasma may be discarded, replaced with donor plasma, or treated with specific substances, depending on the medical condition being addressed.

Plasmapheresis Devices are extracorporeal circulation devices used to collect and/or therapeutically separate blood components. Using centrifugal separation or membrane-based separation within a single-use closed-loop disposable set, they separate whole blood into plasma and cellular components, returning red cells (and other specified components) to the donor/patient in a controlled ratio. Their core value proposition is safe, controllable, and fully traceable separation and reinfusion, improving collection efficiency while reducing operator burden. Typical systems integrate pump/valve and sensor control, a centrifuge rotor or filtration module, precise anticoagulant infusion, pressure/air monitoring, weighing/volume measurement, interlocked alarms, and barcode/e-record interfaces—serving source-plasma collection centers, therapeutic plasma exchange (TPE), and cellular apheresis in hospitals.

Production model: commonly delivered as a bundled model of installed equipment + recurring single-use disposables (tubing/sets) + software upgrades + service/maintenance. OEMs typically combine outsourced modules (motors, sensors, control boards, etc.) with in-house system integration; disposables emphasize medical-grade polymers, precision extrusion/injection molding, sterilization, and validation, while software emphasizes algorithms, data logging, and compliance-ready audit trails.

Gross margin (indicative range): recurring disposables and service typically lift blended margins above ordinary durable equipment; public disclosures from leading players show ~40%–50% gross margin (varying by period and metric), a practical benchmark for the segment.

Value chain: upstream includes medical-grade polymers (disposables), stainless steel/precision parts, pumps/valves/motors/sensors, controls & software; midstream includes system assembly/calibration, disposables molding & sterilization, software verification/system testing, registration & quality systems; downstream includes source-plasma centers/blood establishments and hospital departments performing TPE and cellular apheresis.

Market Development Opportunities & Main Driving Factors

Demand is jointly driven by expanding plasma supply capacity and growing demand for plasma-derived therapies.

Market Challenges, Risks, & Restraints

This is a near-zero-tolerance compliance-and-safety market. In 2024, FDA issued/updated guidance on informed consent and donor-eligibility determination, increasing the “must-have” spend on procedures, data traceability, and quality systems; in China, source-plasma stations are planned and approved under strict rules and are set up by plasma product manufacturers, keeping expansion disciplined. On top of this, sterilized consumables, critical components, and software/cybersecurity supply risks—and EU conformity assessment / notified-body requirements—can lengthen time-to-market and increase cost.

Downstream Demand Trends

Downstream is bifurcating: collection centers prioritize yield per session, throughput, and operational digitization; hospitals performing TPE/cellular apheresis prioritize clinical safety and traceability. Going forward, individualized collection algorithms, integration with donor management systems, and subscription-like procurement of “equipment + single-use disposables + service” will be central levers for customer stickiness and margin structure optimization.

The global major manufacturers of Plasmapheresis Devices include Terumo BCT, Fresenius Kabi, Haemonetics, Baxter, B. Braun, Nikkiso, Miltenyi Biotec, Asahi Kasei Medical, Kaneka Medix, Nigale, Haier Biomedical, Scinomed, Medica SPA, Dahua Medical Instrument, etc. In terms of revenue, the global three largest players hold a 67% market share of Plasmapheresis Devices in 2025.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Plasmapheresis Device market?

What factors are driving Plasmapheresis Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Plasmapheresis Device market opportunities vary by end market size?

How does Plasmapheresis Device break out by Type, by Application?

This report presents a comprehensive overview of the global Plasmapheresis Device market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Desktop Type
• Trolley Type

Segment by Technology

• Centrifugal Separation
• Membrane Separation

Segment by Application

• Extracorporeal Therapy
• Plasma Donation
• Others

Segment by Application

• Hospitals
• Blood Centers
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Plasmapheresis Device market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospitals, Blood Centers, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact